| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 10, 2022 | BLFS Biolife Solutions Inc | Berard Todd67 | Chief Marketing Officer | Sell | 50 | $23.16 | $1,158.00 | - | +0.6% | -55.7% | |
| Nov 10, 2022 | BLFS Biolife Solutions Inc | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 107 | $23.16 | $2,478.12 | - | +0.6% | -55.7% | |
| Nov 10, 2022 | AHCO Adapthealth Corp. | Rietkerk Shaw70 | COO - Centralized Services | Sell | 75,000 | $22.52 | $1,689,060.00 | -33.6% | -9.1% | -69.6% | |
| Nov 10, 2022 | BLFS Biolife Solutions Inc | Aebersold Sarah60 | VP, Global Human Resources | Sell | 38 | $23.16 | $880.08 | -0.1% | +0.6% | -55.7% | |
| Nov 10, 2022 | CERS Cerus Corp | Swisher Daniel N Jr49 | Director | Sell | 12,500 | $3.91 | $48,875.00 | -9.9% | -23.1% | -59.9% | |
| Nov 10, 2022 | BLFS Biolife Solutions Inc | Rice Michael72 | CEO | Sell | 164 | $23.16 | $3,798.24 | - | +0.6% | -55.7% | |
| Nov 10, 2022 | TMDX Transmedics Group, Inc. | Weill David63 | Director | Sell | 21,645 | $56.00 | $1,212,120.00 | -61.6% | +16.0% | +2.1% | |
| Nov 10, 2022 | TMCI Treace Medical Concepts, Inc. | Bays F Barry80 | Director | Sell | 26,523 | $21.92 | $581,432.37 | -0.4% | -11.2% | -73.7% | |
| Nov 9, 2022 | INFU Infusystem Holdings, Inc | Lehman Gregg Owen68 | Director | Sell | 19,743 | $8.96 | $176,806.46 | -98.3% | +16.8% | -3.3% | |
| Nov 9, 2022 | ECIA Encision Inc | Geary Peter D | Director | Buy | 10,000 | $0.46 | $4,600.00 | +25.0% | - | - | |
| Nov 8, 2022 | LUNG Pulmonx Corp | Ferrari Richard59 | Director | Buy | 5,438 | $5.31 | $28,873.78 | +10.0% | +69.9% | +77.2% | |
| Nov 8, 2022 | EW Edwards Lifesciences Corp | Wood Larry L67 | Cvp, Tavr | Sell | 7,242 | $68.50 | $496,064.69 | -3.5% | +13.5% | -5.0% | |
| Nov 8, 2022 | AXGN Axogen, Inc. | Freitag Gregory Gene68 | Director | Sell | 13,000 | $12.50 | $162,500.00 | -3.6% | -22.7% | -55.2% | |
| Nov 8, 2022 | EW Edwards Lifesciences Corp | Bobo Donald E Jr64 | Cvp,Strategy/ Corp Development | Sell | 6,725 | $68.46 | $460,393.50 | -9.7% | +13.5% | -5.0% | |
| Nov 8, 2022 | SMTI Sanara Medtech Inc. | Fleming Zachary B.50 | Chief Executive Officer | Sell | 417 | $33.00 | $13,761.00 | -1.1% | +35.3% | -11.4% | |
| Nov 8, 2022 | ECOR Electrocore, Inc. | Errico Thomas J.65 | Director | Buy | 100,000 | $0.22 | $21,980.00 | +7.0% | +77.3% | +84.6% | |
| Nov 8, 2022 | ISRG Intuitive Surgical Inc | Johnson Amal M60 | Director | Sell | 6,375 | $239.36 | $1,525,904.06 | -36.2% | +3.4% | +15.5% | |
| Nov 8, 2022 | UFPT Ufp Technologies Inc | Bailly R Jeffrey55 | President And CEO | Sell | 8,633 | $115.90 | $1,000,564.70 | -4.5% | -2.3% | +20.7% | |
| Nov 7, 2022 | SYK Stryker Corp | Datar Srikant M.51 | Director | Sell | 300 | $212.36 | $63,707.19 | -5.8% | +27.1% | +28.8% | |
| Nov 7, 2022 | BSX Boston Scientific Corp | Mahoney Michael F57 | Chairman, President &CEO | Sell | 125,827 | $41.97 | $5,280,996.94 | -6.6% | +13.6% | +24.3% | |
| Nov 7, 2022 | RMD Resmed Inc | Sandercock Brett62 | Chief Financial Officer | Sell | 4,000 | $212.02 | $848,067.60 | -3.6% | +4.4% | -29.2% | |
| Nov 7, 2022 | TMDX Transmedics Group, Inc. | Khayal Tamer I53 | Chief Commercial Officer | Sell | 3,044 | $60.04 | $182,761.76 | -70.1% | +14.2% | +5.0% | |
| Nov 7, 2022 | ATEC Alphatec Holdings, Inc. | Sponsel David61 | EVP, Sales | Sell | 10,000 | $9.25 | $92,500.00 | -1.7% | +32.8% | +10.5% | |
| Nov 7, 2022 | IDXX Idexx Laboratories Inc /de | Mazelsky Jonathan Jay63 | President &CEO | Sell | 13,230 | $382.49 | $5,060,319.02 | -2.7% | +26.0% | +9.7% | |
| Nov 7, 2022 | TMDX Transmedics Group, Inc. | Gordon Stephen52 | Chief Financial Officer | Sell | 10,000 | $56.72 | $567,200.00 | -63.6% | +14.2% | +5.0% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.